From July 1, 2022 to September 30, 2022, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 4,416,666 shares, representing 8.39% for $187.87 million under the buyback announced on November 11, 2021.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.015 USD | +8.33% | -2.43% | -16.25% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.25% | 97.45M | |
+24.49% | 672B | |
+24.08% | 550B | |
-5.77% | 351B | |
+15.52% | 317B | |
+7.25% | 292B | |
+3.26% | 211B | |
+0.78% | 203B | |
-9.86% | 144B | |
-6.67% | 141B |
- Stock Market
- Equities
- EBS Stock
- News Emergent BioSolutions Inc.
- Tranche Update on Emergent BioSolutions Inc.'s Equity Buyback Plan announced on November 11, 2021.